Arrestin Mobilizes Signaling Proteins to the Cytoskeleton and Redirects their Activity

Journal of Molecular Biology

Volumn 368, Issue 2, 2007, Pages 375-387

  Hanson, Susan M ^a   Cleghorn, Whitney M ^a   Francis, Derek J ^b   Vishnivetskiy, Sergey A ^a   Raman, Dayanidhi ^a   Song, Xiufeng ^a   Nair, K Saidas ^c   Slepak, Vladlen Z ^c   Klug, Candice S ^b   Gurevich, Vsevolod V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

arrestin; ERK; G protein coupled receptor; Mdm2; microtubules

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN MDM2; RETINA S ANTIGEN; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 33947607229     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.02.053     Document Type: Article

References (59)

1. Carman C.V., and Benovic J.L. G-protein-coupled receptors: turn-ons and turn-offs. Curr. Opin. Neurobiol. 8 (1998) 335-344
2. Gurevich V.V., and Gurevich E.V. The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci. 25 (2004) 105-112
3. Gurevich V.V., and Gurevich E.V. The structural basis of arrestin-mediated regulation of G protein-coupled receptors. Pharmacol. Ther. 110 (2006) 465-502
4. Lefkowitz R.J., and Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 308 (2005) 512-517
5. Xiao K., Shenoy S.K., Nobles K., and Lefkowitz R.J. Activation-dependent conformational changes in beta-arrestin 2. J. Biol. Chem. 279 (2004) 55744-55753
6. Marchese A., Chen C., Kim Y.M., and Benovic J.L. The ins and outs of G protein-coupled receptor trafficking. Trends Biochem. Sci. 28 (2003) 369-376
7. Gurevich V.V., and Gurevich E.V. The new face of active receptor bound arrestin attracts new partners. Structure (Camb) 11 (2003) 1037-1042
8. Nair K.S., Hanson S.M., Kennedy M.J., Hurley J.B., Gurevich V.V., and Slepak V.Z. Direct binding of visual arrestin to microtubules determines the differential subcellular localization of its splice variants in rod photoreceptors. J. Biol. Chem. 279 (2004) 41240-41248
9. Hanson S.M., Francis D.J., Vishnivetskiy S.A., Klug C.S., and Gurevich V.V. Visual arrestin binding to microtubules involves a distinct conformational change. J. Biol. Chem. 281 (2006) 9765-9772
10. Smith W.C., Milam A.H., Dugger D., Arendt A., Hargrave P.A., and Palczewski K. A splice variant of arrestin. Molecular cloning and localization in bovine retina. J. Biol. Chem. 269 (1994) 15407-15410
11. Nair K.S., Hanson S.M., Mendez A., Gurevich E.V., Kennedy M.J., Shestopalov V.I., et al. Light-dependent redistribution of arrestin in vertebrate rods is an energy-independent process governed by protein-protein interactions. Neuron 46 (2005) 555-567
12. Sutton R.B., Vishnivetskiy S.A., Robert J., Hanson S.M., Raman D., Knox B.E., et al. Crystal structure of cone arrestin at 2.3 Å: evolution of receptor specificity. J. Mol. Biol. 354 (2005) 1069-1080
13. Vishnivetskiy S.A., Hirsch J.A., Velez M.G., Gurevich Y.V., and Gurevich V.V. Transition of arrestin in the active receptor-binding state requires an extended interdomain hinge. J. Biol. Chem. 277 (2002) 43961-43968
14. Wang K., Feramisco J.R., and Ash J.F. Fluorescent localization of contractile proteins in tissue culture cells. Methods Enzymol. 85 (1982) 514-562
15. Carter J.M., Gurevich V.V., Prossnitz E.R., and Engen J.R. Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry. J. Mol. Biol. 351 (2005) 865-878
16. Vishnivetskiy S.A., Schubert C., Climaco G.C., Gurevich Y.V., Velez M.G., and Gurevich V.V. An additional phosphate-binding element in arrestin molecule: implications for the mechanism of arrestin activation. J. Biol. Chem. 275 (2000) 41049-41057
17. Celver J., Vishnivetskiy S.A., Chavkin C., and Gurevich V.V. Conservation of the phosphate-sensitive elements in the arrestin family of proteins. J. Biol. Chem. 277 (2002) 9043-9048
18. Gurevich V.V. The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms. J. Biol. Chem. 273 (1998) 15501-15506
19. Gurevich V.V., and Benovic J.L. Visual arrestin interaction with rhodopsin: Sequential multisite binding ensures strict selectivity towards light-activated phosphorylated rhodopsin. J. Biol. Chem. 268 (1993) 11628-11638
20. Gurevich V.V., and Benovic J.L. Cell-free expression of visual arrestin. Truncation mutagenesis identifies multiple domains involved in rhodopsin interaction. J. Biol. Chem. 267 (1992) 21919-21923
21. Gurevich V.V., Dion S.B., Onorato J.J., Ptasienski J., Kim C.M., Sterne-Marr R., et al. Arrestin interaction with G protein-coupled receptors. Direct binding studies of wild-type and mutant arrestins with rhodopsin, β2-adrenergic, and m2 muscarinic cholinergic receptors. J. Biol. Chem. 270 (1995) 720-731
22. Hanson S.M., Francis D.J., Vishnivetskiy S.A., Kolobova E.A., Hubbell W.L., Klug C.S., and Gurevich V.V. Differential interaction of spin labeled arrestin with inactive and active phosphorhodopsin. Proc. Natl Acad. Sci. USA 103 (2006) 4900-4905
23. Hanson S.M., and Gurevich V.V. The differential engagement of arrestin surface charges by the various functional forms of the receptor. J. Biol. Chem. 281 (2006) 3458-3462
24. Han M., Gurevich V.V., Vishnivetskiy S.A., Sigler P.B., and Schubert C. Crystal structure of beta-arrestin at 1.9 Å: possible mechanism of receptor binding and membrane translocation. Structure 9 (2001) 869-880
25. Vishnivetskiy S.A., Hosey M.M., Benovic J.L., and Gurevich V.V. Mapping the arrestin-receptor interface: structural elements responsible for receptor specificity of arrestin proteins. J. Biol. Chem. 279 (2004) 1262-1268
26. Hubbell W.L., Gross A., Langen R., and Lietzow M.A. Recent advances in site-directed spin labeling of proteins. Curr. Opin. Struct. Biol. 8 (1998) 649-656
27. Hubbell W.L., Cafiso D.S., and Altenbach C. Identifying conformational changes with site-directed spin labeling. Nature Struct. Biol. 7 (2000) 735-739
28. Crane J.M., Mao C., Lilly A.A., Smith V.F., Suo Y., Hubbell W.L., and Randall L.L. Mapping of the docking of SecA onto the chaperone SecB by site-directed spin labeling: insight into the mechanism of ligand transfer during protein export. J. Mol. Biol. 353 (2005) 295-307
29. Klug C.S., and Feix J.F. Biomedical EPR - part B: methodology and instrumentation. In: Eaton S.S., Eaton G.R., and Berliner L.J. (Eds). SDSL: a Survey of Biological Applications in Biological Magnetic Resonance vol. 24 (2005), Kluwer Academic/Plenum Publishers, New York, NY 269-308
30. Lietzow M.A., and Hubbell W.L. Motion of spin label side-chains in cellular retinol-binding protein: correlation with structure and nearest-neighbor interactions in an antiparallel beta-sheet. Biochemistry 43 (2004) 3137-3151
31. Columbus L., and Hubbell W.L. A new spin on protein dynamics. Trends Biochem. Sci. 27 (2002) 288-295
32. Mchaourab H.S., Kalai T., Hideg K., and Hubbell W.L. Motion of spin-labeled side-chains in T4 lysozyme: Effect of side-chain structure. Biochemistry 38 (1999) 2947-2955
33. Mchaourab H.S., Lietzow M., Hideg K., and Hubbell W.L. Motion of spin labeled side-chains in T4 lysozyme. Correlation with protein structure and dynamics. Biochemistry 35 (1996) 7692-7704
34. Gundersen G.G., and Cook T.A. Microtubules and signal transduction. Curr. Opin. Cell Biol. 11 (1999) 81-94
35. Amos L.A. Focusing-in on microtubules. Curr. Opin. Struct. Biol. 10 (2000) 236-241
36. Goodman Jr. O.B., Krupnick J.G., Santini F., Gurevich V.V., Penn R.B., Gagnon A.W., et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383 (1996) 447-450
37. Laporte S.A., Oakley R.H., Zhang J., Holt J.A., Ferguson s.S.G., Caron M.G., and Barak L.S. The β2-adrenergic receptor/β-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl Acad. Sci. USA 96 (1999) 3712-3717
38. McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.T., et al. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290 (2000) 1574-1577
39. Luttrell L.M., Roudabush F.L., Choy E.W., Miller W.E., Field M.E., Pierce K.L., and Lefkowitz R.J. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl Acad. Sci. USA 98 (2001) 2449-2459
40. Luttrell L.M. "Location, location, location": activation and targeting of MAP kinases by G protein-coupled receptors. J. Mol. Endocrinol. 30 (2003) 117-126
41. Shenoy S.K., and Lefkowitz R.J. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J. Biol. Chem. 278 (2003) 14498-14506
42. Wang P., Gao H., Ni Y., Wang B., Wu Y., Ji L., et al. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J. Biol. Chem. 278 (2003) 6363-6370
43. Song X., Raman D., Gurevich E.V., Vishnivetskiy S.A., and Gurevich V.V. Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm. J. Biol. Chem. 281 (2006) 21491-21499
44. Shenoy S.K., McDonald P.H., Kohout T.A., and Lefkowitz R.J. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294 (2001) 1307-1313
45. Hupfeld C.J., Resnik J.L., Ugi S., and Olefsky J.M. Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors. J. Biol. Chem. 280 (2005) 1016-1023
46. Hiller G., and Weber K. Radioimmunoassay for tubulin: a quantitative comparison of the tubulin content of different established tissue culture cells and tissues. Cell 14 (1978) 795-804
47. Ackmann M., Wiech H., and Mandelkow E. Nonsaturable binding indicates clustering of tau on the microtubule surface in a paired helical filament-like conformation. J. Biol. Chem. 275 (2000) 30335-30343
48. Wang N., Yan K., and Rasenick M.M. Tubulin binds specifically to the signal-transducing proteins, Gs alpha and Gi alpha 1. J. Biol. Chem. 265 (1990) 1239-1242
49. Pitcher J.A., Hall R.A., Daaka Y., Zhang J., Ferguson S.S., Hester S., et al. The G protein-coupled receptor kinase 2 is a microtubule-associated protein kinase that phosphorylates tubulin. J. Biol. Chem. 273 (1998) 12316-12324
50. Carman C.V., Som T., Kim C.M., and Benovic J.L. Binding and phosphorylation of tubulin by G protein-coupled receptor kinases. J. Biol. Chem. 273 (1998) 20308-20316
51. Santini F., Penn R.B., Gagnon A.W., Benovic J.L., and Keen J.H. Selective recruitment of arrestin-3 to clathrin coated pits upon stimulation of G protein-coupled receptors. J. Cell Sci. 113 (2000) 2463-2470
52. Pulvermuller A., Schroder K., Fischer T., and Hofmann K.P. Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin. J. Biol. Chem. 275 (2000) 37679-37685
53. Girnita L., Shenoy S.K., Sehat B., Vasilcanu R., Girnita A., Lefkowitz R.J., and Larsson O. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J. Biol. Chem. 280 (2005) 24412-24419
54. Wang Y.Y.T., Teng L., Wu Y., Zhao X., and Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nature Immunol. 7 (2006) 139-147
55. Scott M.G., Le E., Rouzic A., Perianin V., Pierotti H., Enslen S., Benichou S., and Marullo A. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. J. Biol. Chem. 277 (2002) 37693-37701
56. Gurevich V.V. Use of bacteriophage RNA polymerase in RNA synthesis. Methods Enzymol. 275 (1996) 382-397
57. Gurevich V.V., and Benovic J.L. Arrestin: mutagenesis, expression, purification, and functional characterization. Methods Enzymol. 315 (2000) 422-437
58. Gurevich V.V., Richardson R.M., Kim C.M., Hosey M.M., and Benovic J.L. Binding of wild-type and chimeric arrestins to the m2 muscarinic cholinergic receptor. J. Biol. Chem. 268 (1993) 16879-16882
59. Donoso L.A., Gregerson D.S., Smith L., Robertson S., Knospe V., Vrabec T., and Kalsow C.M. S-antigen: preparation and characterization of site-specific monoclonal antibodies. Curr. Eye Res. 9 (1990) 343-355